There are many limitations for conducting liver disease research in human beings due to the high cost and potential ethical issues. For this reason, conducting a study that is difficult to perform in humans using appropriate animal models, can be beneficial in ascertaining the pathological physiology, and in developing new treatment modalities. However, it is difficult to determine the appropriate animal model which is suitable for research purposes, since every patient has different and diverse clinical symptoms, adverse reactions, and complications due to the pathological physiology. Also, it is not easy to reproduce identically various clinical situations in animal models. Recently, the Guide for the Care and Use of Laboratory Animals has tightened up the regulations, and therefore it is advisable to select the appropriate animals and decide upon the appropriate quantities through scientific and systemic considerations before conducting animal testing. Therefore, in this review article the authors examined various white rat animal testing models and determined the appropriate usable rat model, and the pros and cons of its application in liver disease research. The authors believe that this review will be beneficial in selecting proper laboratory animals for research purposes.
Introduction
There are many limitations in conducting liver disease research directly in human beings due to the high cost, and particularly due to the potential ethical issues. 1 In other words, conducting a study that is difficult to perform in humans using appropriate animal models, can be advantageous in ascertaining the pathological physiology and in developing new treatment modalities. 2 Nevertheless, it is difficult to determine the appropriate animal model which is suitable for research purposes, since every patient has different and diverse clinical symptoms, adverse reactions, and complications due to the pathological physiology. Also, identical reproduction of various clinical situations in animal models may not be feasible. Recently, the Guidelines for the Care and Use of Laboratory Animals has become stringent, and therefore it is advisable to select the Therefore, in this review article we attempted to search various rat animal experimental models, and to determine the appropriate usable rat model, and investigate the pros and cons of its application in liver disease research. We believe that this review will be beneficial in selecting
proper laboratory animals for research purposes.
Acquisition of the Experimental Animal Model
Many animals are utilized in studies of disease development process and biochemical studies, in humans.
The majority of animal models have dissimilar explanations for the conditions or diseases that occur in humans, but they are absolutely essential for the advancement of physiomedical knowledge. The basic criteria for an ideal experimental animal model are as follows: [3] [4] [5] 1) It should accurately reproduce the disease that is being researched.
2) It should be accessible to many researchers.
3) It should be exportable to other laboratories.
4) It should be adequate enough to provide an appropriate quantity of samples.
5) It should be easily handled by researchers.
6) It should survive long enough to be usable.
7) It should adapt well to the breeding environment.
8) It should be available in multiple species.
9) It should be in a polytocous species.
Animal disease models are divided into two types:
spontaneous and experimentally induced models. Spontaneous animal models can be used as human disease models. These models resemble the human disease compared to experimentally induced models. Experimentally induced models can be created either through surgical modifications, genetic modifications, chemical modifications, and biological modifications. The classic examples of experimentally induced models are chemically induced diabetes models and neoplastic models, which have been reported to be used in many studies. Recently, the genetically engineered models have emerged as the most prevalent experimentally induced model, but their application are more common in mice than in rats.
However, for surgical experimentation, rats are preferred to mice as rat is larger and therefore is more advantageous and ideal. The above mentioned ideal conditions for animal experiments are also applicable to rats, and rats which meet the animal model criteria are procured easily from supply companies ( Table 1) . Examples of the more common species of rats used in animal models are Wistar, Sprague-Dawley, Osborne-Mendel, Long-Evans, Holtzman, Slonaker, and Albany. 
Rat Strains
In 1959, Billingham RHK and Silvers first defined the rat species, and more than 220 species of inbred strains and many substrains are now present. 6 Inbreeding is defined as 20 or more times of breeding between offsprings or between parents and offspring, and since this is a highly genetically isogenic strain, a 'unique species' reaction may be obtained. In outbreeding, breeding is continued within a specified group which is less closely related than that in inbreeding, and was originally derived from inbreeding. Although in outbreeding, the uniformity of genetic composition is less consistent than in inbreeding animals, the reproduction rate is higher and breeding is relatively easy, and therefore outbred animals play an important function in biological examination.
Liver Disease Experimental
Animal Models
Types of liver disease experimental animal models
The liver disease experimental animal models are divided into 2 types ( Table 2 ).
The first category is the genetically determined disease model. Examples of genetically determined disease models are the Gunn rat in which there is deficient bilirubin metabolism (Crigler-Najjar syndrome), 7 the Long-Evans Cinnamon (LEC) rat in which there is deficient copper metabolism (Wilson's disease), 8 and rats with deficient albumin production; the Nagase analbuminemic rat (NAR), and the analbuminemic congenic strains of rats; ACI-alb, F344-alb and SHR-alb. 9 Others examples are the spontaneously hypertensive rat (SHR), the diabetic rat (OLETF), and the obese rat (Zucker rat).
The second type of experimental animal models comprises of the drug induced or surgically induced models.
Metabolic liver disease animal models
Metabolic liver disease animal models were developed by genetic mutations as they share various clinical characteristics, side effects, complications in humans according to the individual pathological physiology. The liver parenchyma and thousands of other metabolic functions are normal in the patients with this disease, but they are at risk of severe neurologic complications.
Orthotopic liver transplantation is the radical treatment 14 Gunn rats are derived from the Wistar species and cause unstoppable elevations of serum bilirubin leading to unconjugated hyperbilirubinemia. The Gunn rats inherently lack all the glucuronidation activity catalyzed by the UGT1 isoform. Therefore, these rats are used in the animal experiment models for investigation of type I Crigler-Najjar (CN) syndrome.
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2) Long Evans Cinnamon (LEC) rat (Wilson's disease)
The LEC rat was discovered in 1983 at the Center for Experimental Plants and Animals, Hokkaido, Japan, and is characterized by the unique cinnamon colored fir, and is similar to the mutation form of the Long-Evans rat. 17 The LEC rat is an appropriate animal model for the study of the importance of hepatitis in the development of hepatomas.
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The species with this mutation self expresses chronic hepatitis followed by an extremely high incidence of preneoplastic lesions and hepatomas ( Fig. 1 ).
That is, the LEC rat shows a remarkable similarity to the clinical course of liver cancer development in humans.
Recently, the spontaneous hepatitis shown in LEC rats is thought to be related to high copper accumulation in the liver, and this is probably due to the problems in the excretion of copper from the blood and bile by the liver.
Therefore, the occurrence of liver cancer can be controlled by reducing the copper content in the feed provided to the laboratory animals, and it can theoretically be deduced whether liver cancer develops in association with hepatitis. 3) Nagase analbuminemic (NAR) rat (Analbuminemia)
Analbuminemia in humans was first described by
Benhold. In 1959, and the etiology and metabolic aspects of this condition have been studied by other researchers. Compared to the rat presenting albumin, the liver and adrenals of analbuminemic syngeneic white rat show increase in weight from 30 weeks onwards. Also, the serum lipid levels appear to be higher at the same time. First, the degree of acute liver failure must be reversible so that survival is likely after effective therapy.
Second, identical death rates should be reproducible when inconsistent treatment is given.
Third, selective liver damage must be the cause of death.
Fourth, a therapeutic window must be obtained.
Fifth, the animal must be large enough so that the treatment can be administered in humans.
Sixth, the hazard to the studying person should be minimized.
The six standards suggested above are known as the basic requisites for animal models of acute liver failure.
Newsome suggested 2 additional items. 4 Seventh, the animal model should have metabolic or physiological mechanisms similar to that in humans.
Eighth, animal experimental methods should adhere to appropriate ethical standards.
1) Surgical models
Surgical animal models are classified into 3 types;
anhepatic model, partial hepatectomy model, and the devascularization model. (3) Devascularization model: Mechanisms of injury due to devascularization are at present known to be very complex. 35 In ischemic damage, suppression of oxidative phosphorylation leads to decreased ATP and defects in mitochondrial States, the frequency of acetaminophen abuse is rapidly increasing. 47 Acetaminophen metabolism occurs in the liver.
Under normal conditions, acetaminophen glucuronidation and sulfation leads to biotransformation and excretion. If this mechanism becomes overloaded then acetaminophen is metabolized by the cytochrome P450 oxidative enzyme. [48] [49] [50] [51] Subsequently this results in the production of a toxic metabolite N-acetyl-p-benzoquinoneimine (NAPQI), by non-conjugation of acetaminophen with endogenous glutathione. [52] [53] [54] The toxic properties of NAPQI have been attributed to the formation of free radicals, reactive oxygen species, hydroxyl radicals, nitrites and nitrates, which obstruct the mitochondrial calcium channel and cell injury. 55 This chain reaction is amplified by the production of cytokines and free radicals that cause apoptosis and necrosis of Kupffer cells. This is characterized particularly by the adequate presence or absence, efficiency, species diversity and senility of the cytochrome P450 oxidative enzyme. [56] [57] [58] 2E1 and 1A2 are the members of the cytochrome P450 family that are the most closely related to acetaminophen metabolism. To date many models are being researched to establish an acetaminophen model.
The hepatotoxic properties of CCl4 have been known for a long period of time. 59, 60 CCl4 was extensively employed in acute liver injury models in the 1970s and the early 1980s, but after it was revealed that reproducibility was not up to the desired standards, along with questions regarding species diversity, 61,62 it was not used further. Recently, a model has emerged in which CCl4 is administered into the stomach and intraperitoneally to induce liver cirrhosis. 63, 64 The cytochrome P450 enzyme is considered to participate in the production of CCl4 metabolites. 59, 65, 66 In 71 and is thought to cause apoptosis at low concentrations. However, if the doses are increased, electrophiles and free radicals are released which contribute to lipid peroxidation and centrilobular necrosis and are then expelled. 72 TAA is widely employed as an agent to induce acute liver failure in rats and mice, but it has been suggested that the use of other animals may lead to species variability. In models using rabbits there is definite variability with respect to clinical and histological change.
Clinical characteristics such as encephalopathy, metabolic acidosis, high levels of transaminase, abnormal coagulopathy, and centrilobular necrosis were observed after intraperitoneal TAA administration in rats, and these manifestations reached their peak after 12∼24 hours. [72] [73] [74] Administration doses ranged from 400 mg/kg to 600 mg/kg, and intervals varied from once a day for 2 days to once a day for 3 days. Recent reports have successed to show liver cirrhosis development after chronic administration of TAA. 64, 75, 76 The authors of this review have also experienced induction of liver cirrhosis via various routes of TAA administration. 77 
Conclusions
Animal model experiments have recently contributed to proof of theories and delineation of the pathophysiology.
It is of utmost importance to gain accurate knowledge via various animal experiments for an appropriate selection of the ideal animal model for research. High reproducibility and simple animal models that will provide high quality research will contribute to our academic development.
